Literature DB >> 11730992

Quantification of late complications after radiation therapy.

H Jung1, H P Beck-Bornholdt, V Svoboda, W Alberti, T Herrmann.   

Abstract

BACKGROUND: An increasing number of patients survive cancer after having received radiation therapy. Therefore, the occurrence of late normal tissue complications among long-term survivors is of particular concern.
METHODS: Sixty-three patients treated by radical surgery and irradiation for rectal carcinoma were subjected to an unconventional sandwich therapy. Preoperative irradiation was given in four fractions of 5 Gy each applied within 2 or 3 days; postoperative irradiation consisted mostly of 15 x 2 Gy (range, 20-40 Gy). A considerable proportion of these patients developed severe late complications (Radiother Oncol 53 (1999) 177). The data allowed a detailed analysis of complication kinetics, leading to a new model which was tested using data from the literature.
RESULTS: Data on late complications were obtained for eight different organs with a follow-up of up to 10 years. For the various organs, the percentage of patients being free from late complications, plotted as a function of time after start of radiation therapy, was adequately described by exponential regression. From the fit, the parameter p(a) was obtained, which is the percentage of patients at risk in a given year of developing a complication in a given organ during that year. The rate p(a) remained about constant with time. Following sandwich therapy, the annual incidence of complications in the bladder, ileum, lymphatic and soft tissue, and ureters was about the same (p(a)=10-14%/year), whereas complications in bone or dermis occurred at lower rates (4.7 or 7.5%/year, respectively). DISCUSSION: Numerous data sets collected from published reports were analyzed in the same way. Many of the data sets studied were from patients in a series where there was a high incidence of late effects. Three types of kinetics for the occurrence of late effects after radiotherapy were identified: Type 1, purely exponential kinetics; Type 2, exponential kinetics, the slope of which decreased exponentially with time; Type 3, curves composed of two components, a fast initial decline followed by an exponential decrease. For each kind of kinetics, provided that the dose distribution is not too heterogeneous, the incidence of late effects appears to occur at exponential or approximately exponential kinetics, even many years after treatment. This implies that a random process might be involved in the occurrence of late radiation sequelae.
CONCLUSIONS: There might be a lifelong risk of developing late complications, of which patients and clinicians should be aware. It appears worthwhile to try to identify, in follow-up examinations of patients after radiation therapy, what kind of processes might be involved in triggering subclinical residual injury to develop into a clinically manifest late effect.

Entities:  

Mesh:

Year:  2001        PMID: 11730992     DOI: 10.1016/s0167-8140(01)00457-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  14 in total

Review 1.  New approach to anal cancer: individualized therapy based on sentinel lymph node biopsy.

Authors:  Paola De Nardi; Michele Carvello; Carlo Staudacher
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

2.  Proctocolectomy for colorectal cancer--is the ileal pouch anal anastomosis a safe alternative to permanent ileostomy?

Authors:  Ryan Snelgrove; Carl J Brown; Brenda I O'Connor; Harden Huang; J Charles Victor; Robert Gryfe; Helen MacRae; Zane Cohen; Robin S McLeod
Journal:  Int J Colorectal Dis       Date:  2014-10-17       Impact factor: 2.571

3.  Late complications after radiotherapy for prostate cancer.

Authors:  H Jung; H-P Beck-Bornholdt; V Svoboda; W Alberti; T Herrmann
Journal:  Strahlenther Onkol       Date:  2012-10-11       Impact factor: 3.621

Review 4.  Pathophysiology of Radiation-Induced Dysphagia in Head and Neck Cancer.

Authors:  Suzanne N King; Neal E Dunlap; Paul A Tennant; Teresa Pitts
Journal:  Dysphagia       Date:  2016-04-20       Impact factor: 3.438

5.  Fractionated irradiations lead to chronic allergic airway inflammation through increasing the influx of macrophages.

Authors:  Hae-Ran Park; Sung-Kee Jo; Dong-Kyung Yu; Uhee Jung
Journal:  Inflamm Res       Date:  2012-08-23       Impact factor: 4.575

6.  The risk to develop a recurrence of a gastric cancer-is it independent of time?

Authors:  Uwe Klinge; Diana Ackermann; Petra Lynen-Jansen; Peter R Mertens
Journal:  Langenbecks Arch Surg       Date:  2008-01-04       Impact factor: 3.445

Review 7.  Late Sequelae of Radiotherapy—The Effect of Technical and Conceptual Innovations in Radiation Oncology.

Authors:  Ulrike Hoeller; Kerstin Borgmann; Michael Oertel; Uwe Haverkamp; Volker Budach; Hans Theodor Eich
Journal:  Dtsch Arztebl Int       Date:  2021-03-26       Impact factor: 5.594

8.  Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy.

Authors:  Annette Raabe; Katharina Derda; Sebastian Reuther; Silke Szymczak; Kerstin Borgmann; Ulrike Hoeller; Andreas Ziegler; Cordula Petersen; Ekkehard Dikomey
Journal:  Radiat Oncol       Date:  2012-04-26       Impact factor: 3.481

9.  Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.

Authors:  Escarlata López; Rosario Guerrero; Maria Isabel Núñez; Rosario del Moral; Mercedes Villalobos; Joaquina Martínez-Galán; Maria Teresa Valenzuela; José Antonio Muñoz-Gámez; Francisco Javier Oliver; David Martín-Oliva; José Mariano Ruiz de Almodóvar
Journal:  Breast Cancer Res       Date:  2005-07-01       Impact factor: 6.466

10.  Skin elasticity as a measure of radiation fibrosis: is it reproducible and does it correlate with patient and physician-reported measures?

Authors:  Nhu-Tram A Nguyen; David Roberge; Carolyn R Freeman; Cindy Wong; Jerod Hines; Robert E Turcotte
Journal:  Technol Cancer Res Treat       Date:  2013-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.